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Abstract 
OBJECTIVE: The current study was designed to determine the hepatoprotective effect of well-known drugs. 
Nitroglycerin, N-acetyl cysteine and Metoprolol in acute liver injury induced by CCL4. The antioxidant effects of b-
blockers, especially carvedilol, have been described by several investigators. However, for metoprolol, the effect 
is a bit query as there is only one in-vitro study showing a little hepatoprotective effect. Thus, it is worthy to re-
study the hepatoprotective effect of metoprolol.  
AIM: To explore the possible hepatoprotective effect of Nitroglycerin, N-acetyl cysteine and Metoprolol Tartrate 
MATERIAL AND METHODS: The normal serum values of ALP, AST, ALT, TSB and TSP were determined in 35 
healthy rabbits allocated to 5 groups before CCL4 induction and at three occasions 24, 72, 120 hrs after induction 
by CCL4 and treatment with the tested drugs: Nitroglycerin, N-acetyl cysteine and Metoprolol for five successive 
days. 
RESULTS: Showed significant decrease in serum levels of ALP, AST, ALT and TSB with a significant increase in 
TSP level of all the tested drugs measured at 120 hrs compared with the control and their levels measured at 24, 
72 hrs. 
CONCLUSION: All the tested drugs proved in having a hepatoprotective effect when they are given orally to 
animals. The histopathological sections of the liver tissue supported the real effect of these drugs in the 
management of ALI. 
 
 
 
 
Introduction 
 
Acute liver injury (ALI), is a clinical state that 
results from severe and extensive damage of liver 
tissue with reduced cell mass and blood flow. It is 
associated with an increase in serum alanine 
aminotransferase (ALT), aspartate aminotransferase 
(AST), alkaline phosphatase (ALT), and total serum 
bilirubin (TSB) [1], [2], [3].  
It is a serious condition caused by different 
agents toxins, drug intoxication, and other factors [4], 
[5]. It is characterised by rapid deterioration of the liver 
cells function, resulting in hepatic encephalopathy & 
coagulopathy in the liver of normal subjects [6]. 
Carbon tetrachloride (CCL4), is a famous 
hepatotoxic agent that used orally or intraperitoneally 
in animals (especially in rodents) for the induction of 
ALI due to the formation of free radicals mediated lipid 
peroxidation [7].  
Carbon tetrachloride (CCL4) is a well-known 
hepato-toxicant via causing oxidative stress-mediated 
liver injury and has a similar mechanism in animals 
and humans [8].  
CCL4 toxicity results from its bioactivation to 
the highly toxic reactive trichloromethyl peroxyl radical 
that subsequently attack the polyunsaturated fatty 
acids of cell membranes to propagate a chain reaction 
resulting in peroxidative decomposition of cytoplasmic 
membrane lipids [9], leading to progression of liver 
damage with subsequent hepatocellular carcinoma 
[10]. 
A single dose of CCL4 causes centrizonal 
necrosis and steatosis [11], while prolonged 
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administration causes liver fibrosis, cirrhosis, and 
hepatocellular carcinoma [12]. CCL4 affects 
hepatocytes directly by altering the permeability of the 
plasma, mitochondrial, and lysosomal membranes. 
Highly reactive free radicals are also produced by the 
mixed function oxidase system of CYP2E1 in 
hepatocytes, causing severe centrilobular necrosis 
[13], [14]. This model has been used extensively to 
examine the pathogenesis of cirrhosis. Liver fibrosis is 
the pathologic result of ongoing chronic inflammatory 
liver diseases that is characterised by hepatic stellate 
cell (HSC) proliferation and differentiation to 
myofibroblast-like cells, which deposit collagen and 
extracellular matrix [15].  
Several familiar drugs had been proved in 
having hepatoprotective activity against CCL4 induced 
model of ALI [16]. It is interesting to explore the 
possible hepatoprotective effect of Nitroglycerin, N-
acetyl cysteine and Metoprolol Tartrate in the current 
study. 
 
 
Material and Methods 
 
Chemicals 
All chemicals used are of analytic grades. 
CCL4 was supplied by Merck-Germany as a pause 
liquid. Nitroglycerin by Amrit medical center-Syria, N-
acetyl cysteine powder from Cimex AG Ltd-
Switzerland, Metoprolol tartrate from Al Parma, Barn- 
staple. The UK. The kits for the estimation of ALP, 
AST, ALT was purchased from BioMérieux- France 
while that for TSB & TSP from Randox-England. 
 
Animals 
Thirty-five healthy domestic rabbits weighing 
700-800 gm were used in the present study. They 
were supplied by the animal house of Pharmacy 
College. Animals were housed in separated cages 
under good conditions of 28°C with 12 hrs of the 
light/dark cycle. They were fed standard oxoid pellets 
and were given water ad libitum. 
The study was conducted according to the 
animal ethics committee of Al-Nahrain College of 
Medicine (approval number: 2016/24156). The rabbits 
were normally allocated to five groups. They were 
given a single daily dose of the following drugs for five 
successive days at 8.00 am.  
Group-1: (control), received 3 ml of distilled 
water orally and without CCL4 administration.  
Group-2: (drug control), received 3 ml of 
distilled water orally. 
Group-3: received Nitroglycerin 1 mg/kg 
orally. 
Group-4: received N-acetyl cysteine 275 
mg/kg orally.  
Group-5: received Metoprolol 7 mg/kg orally.  
The doses of Nitroglycerin, N-acetyl cysteine 
and Metoprolol tartrate had been chosen after many 
trials in a pilot study.  
At 9.00 a.m. on the first day, CCL4 was given 
to animals of groups 2, 3, 4 and 5 in a dose of 1 
mg/kg orally for induction of ALI. Blood samples were 
collected from marginal ear vein of the rabbits of all 
groups for biochemical analysis of serum AST, ALT, 
ALP, TSB and TSP at three occasions, 24, 72, 120 
hrs using spectrophotometer method [17] for 
comparison between the value of these results.  
Later on, all the rabbits were sacrificed under 
light anaesthesia of Diethyl ether (ether) to take 
specimens of the liver. The histopathological 
examination was carried out to check the microscopic 
changes in the liver tissue, using a polarised 
microscope after fixating the sections in 10% formalin 
for 48 hrs & staining with hematoxylin & eosin [18]. 
 
Statistical analysis 
The obtained results were expressed as 
means ± SEM. The difference among means has 
been analysed by students t-test using SPSS version 
12. P values < 0.05 were considered to be significant.  
 
 
Results  
 
Administration of CCL4 to the rabbits in the 
group -2 produced a marked increase in serum AST, 
ALT, ALP &TSB levels with a decrease in TSP level 
compared with normal control (group-1). Both 
nitroglycerine (group-3) & N-acetylcysteine (group-4) 
revealed significant reduction in serum ALP, AST, 
ALT & TSB levels with significant elevation of TSP 
level when compared with the control (group-2) & their 
levels at 24, 72, 120 hrs. N-acetyl cysteine (NAC) was 
more potent than nitroglycerine in improving hepatic 
function test significantly especially ALT, AST & TSP 
with values 30.17 ± 3.46 , 29.67 ± 3.51 and 30.83 ± 
2.41 and 5.03 ± 0.16 respectively for nitroglycerin 
while nitroglycerin was more potent in changing ALP 
and TSB significantly than NAC with values 44.45 ± 
3.3 ,11.3 ± 0.28 respectively versus 48.17 ± 4.05, 11.6 
± 0.21 for NAC respectively measured at 120 hr. 
Metoprolol showed a significant decrease of AST at 
different occasions in comparison with the drug 
control while serum ALT, ALP levels significantly 
decreased at 24 hr p < 0.05 in comparison with 72, 
and 120 hr. 
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Table-1 Serum levels of ALT, AST, ALP with TSB & TSP of 
tested drugs: nitroglycerine, NAC, metoprolol tartrate after 
induction of ALI by CCL4 measured at 24, 72 & 120 hrs 
Group Dose 
Duration 
(hr) 
S. ALT U/L S. AST U/L S. ALP U/L TSB Umol/ L TSP g/dl 
Normal 
control 
  23.72±0.94 23.38±1.38 49.03±3.23 11.27±0.61 5.58±0.11 
CCL4 
alone 
1ml/K
g 
24hr 133.32±2.72a 208.45±3.73a 206.35±3.3a 30.57±1.21a 4.3±0.23a 
72hr 115.12±4.76 b 194.38±5.15 a  204.05±4.25a 26.70±1.57ab 4.60±0.17a 
120hr 97.83±3.97b 146.52±6.15b 189.98±5.21a 20.13±1.56a 4.58±0.16a 
Nitro-
glycerine 
1ml/K
g 
24hr 92.17±1.17a 144.17±2.21a 126.83±2.80a 14.38±0.35a 4.45±0.57a 
72hr 78.50±4.02b 108.50±6.84b 44±3.87b 13.38±0.25b 5.03±0.08b 
120hr 40.42±3.10c 30.83±2.41c 44.45±3.30b 11.30±0.28c 5.03±0.16b 
N-acetyl 
cysteine 
275m
g/kg 
24hr 82.17±4.47a 118.17±4.94a 109.17±7.35a 13.73±0.40a 4.85±0.89a 
72hr 65.67±2.62b 84.67±4.41b 62.83±4.05b 11.77±0.30b 5.12±0.79ab 
120hr 30.17±3.46c 29.67±3.51c 48.17±4.05c 11.60±0.31b 5.28±0.13b 
Metoprolol 
tartrate 
7mg/k
g 
24hr 84.76±4.70a 102.53±2.12a 132.78±7.71a 13.62±0.68a 4.70±0.97a 
72hr 64.47±2.90b 93.87±1.83b 105.77±3.48b 12.30±0.38a 4.87±0.72a 
120hr 64.40±2.27b 85.70±2.45c 96.30±4b 11.58±0.49a 4.83±0.13a 
Same letters mean non-significant lowering effect at (P> 0.05); -Different letters mean 
significant lowering effect at (P< 0.05).  
 
 
Histopathological studies of liver sections 
supported the results obtained from serum enzymes 
assays, which demonstrated the normal architecture 
in rabbits of Group-1 (Figure 1). 
 
Figure 1: Normal rabbit liver section showing hepatocyte 
architecture with normal lobular appearance (40X, H&E stain) 
 
Whereas the liver sections of rabbits in group-
2 showed a total loss of hepatic architecture with 
massive fatty changes, intense necrosis, congestion 
and infiltration of the lymphocytes around the central 
vein (Figure 2).  
 
Figure 2: Liver section after administration of CCL4 showing 
massive necrosis, fatty changes, congestion and lymphocyte 
infiltration (40X, H&E stain) 
 
The liver sections in rabbits of Group 3, 4 and 
5 showed a more or less normal lobular pattern with a 
mild degree of congestion, fatty changes and mild 
lymphocytes infiltration with minimal necrosis or no 
necrosis indicating the hepatoprotective effect of 
nitroglycerin NAC & metoprolol tartrate (Figures 3A, 
3B, and 3C). 
A)
 
B)
 
C)
 
Figure 3: 3A) Liver section after CCL4 and nitroglycerine 
administration showing mild to moderate fatty changes, congestion 
& minimal necrosis (40X, H&E stain); 3B) Liver section after CCL4 
and N-acetyl cysteine administration showing very minimal fatty 
changes with congestion and minimal necrosis (40X, H&E stain); 
3C) Liver section after CCL4 and metoprolol tartrate administration 
showing severe fatty changes, mild congestion with multifocal 
hepatocellular necrosis (40X, H&E stain) 
 
 
 
Discussion 
 
The hepatotoxicity of CCL4 is well known for 
the induction of ALI in the experimental animal model. 
CCL4 is biotransformed in the cytochrome P-450 
system to its metabolite trichloro-methyl free radical 
(ccl3) which in the presence of O2 forms trichloro- 
methyl-peroxyl free radical (ccl3O2 that attacks lipid of 
endoplasmic reticulum, eliciting lipid peroxidation with 
the leakage of hepatocellular enzymes AST, ALT and 
ALP in the serum causing a significant increase in 
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TSB and a decrease in TSP [18]. The results of the 
drug control (Group-2) in the current study are 
compatible with the results of others [19], [20] who 
demonstrated that changes of CCL4 at day one might 
correspond to liver intoxication then the changes 
decrease at day four due to the normal physiology of 
liver regeneration [21].  
Administration of nitroglycerin, which is an 
effective vasodilator drug in the treatment of angina 
pectoris (Group-3) produced significant positive 
results in improving ALI induced by CCL4. The results 
were more evident when given in a dose-dependent 
manner [22]. Nitroglycerin is a member of organic 
nitrate with antioxidant activity [23]. It causes the 
release of nitric oxide (NO), thus the hepatoprotective 
effect of the drug attributed to the effect of NO 
inactivation of guanylyl cyclase leading to the 
synthesis of CAMP (T3) [24]. Nitric oxide proved in 
having antiapoptotic activity in the hepatocytes. It has 
been shown in the following study to ameliorate the 
rise of ALT, AST and improve the histopathological 
changes that were induced by CCL4 administration 
[25], [26]. 
N-acetyl cysteine (NAC) is a mucolytic agent 
that reduces the viscosity of secretions & used in 
paracetamol poisoning (Group-4) [27]. NAC has an 
antioxidant and anti-inflammatory effect [28] when 
used in vivo & in vitro. It is a source of sulfhydryl 
group that indirectly increase GSH supply for 
glutathione peroxidase & directly reacts with reactive 
oxygen species [29]. 
The results of NAC in the current study were 
similar to the results of others [30] who used NAC 
against liver damage induced by methotrexate 
causing a decrease in GSH level & superoxide 
dismutase and catalase activity & increase in 
malondialdehyde level. Moreover, N-acetyl cysteine 
has been shown in previous studies to improve the 
paracetamol and phenacetin induced hepatic and 
blood, biochemical, and histopathological 
disturbances. It has an antioxidant and 
hepatoprotective efficacy against the drug-induced 
liver injury [31]. 
Metoprolol tartrate is a selective B1 
adrenoceptor blocking drug (Group-5) produces a 
negative chronotropic & inotropic effect and can lower 
HDL level used in prophylaxis of hypertension and 
angina pectoris [32]. The antioxidant effect of 
metoprolol in vitro has been studied and described 
previously [1]. The antioxidant properties of metoprolol 
in vivo are a little bit query as there is only one study 
showing a little hepatoprotective effect [2]. Many 
drugs with putative antioxidant effects require high 
concentration or show antioxidant effects only under 
in vitro conditions. Thus, the real contribution of the 
putative antioxidant eﬀects of metoprolol to its 
eﬃcacy as a hepatoprotective agent was explored in 
our study. This is a very important issue because this 
may provide a valuable contribution for the ﬁnal 
healing outcome. 
In conclusion, nitroglycerine, N-acetyl 
cysteine & metoprolol tartrate had proved in having a 
hepatoprotective effect by increasing the normal 
hepatic function & enhancing the biodefense of the 
liver tissue against the oxidative damage produced by 
CCL4 administration.  
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